The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Additional Listing

5 Nov 2018 07:00

RNS Number : 1905G
Huntsworth PLC
05 November 2018
 

 

 

Huntsworth plc (the Company)

 

5 November 2018

Additional Listing

The Board of Huntsworth, the healthcare and communications group, announces that pursuant to the proposed interim dividend of 0.7 pence per ordinary share announced on 24 July 2018 and payable on 6 November 2018, the Company announces that it has received valid elections for a scrip dividend alternative in respect of 97,709 new ordinary shares of 1p each in the capital of the Company (New Shares).

An application has been made to the UK Listing Authority and to the London Stock Exchange for the New Shares to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities (Admission). It is expected that Admission will occur at 8.00 a.m. on 6 November 2018.

The New Shares will rank pari passu with the existing ordinary shares of 1p each.

For further information please contact:

Enquiries to:

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Angharad Couch

 

Nick Reading

 

Elizabeth Kittle

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSFKBDQKBDDCDK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.